July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...
July 18, 2024 — AliveCor, a global leader in AI-powered cardiology, today announced that the American Medical ...
July 17, 2024 — HeartFlow, a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...
On July 16, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows ...
July 16, 2024 — Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
July 16, 2024 — Ultrahuman, a pioneer in wearable technology, launches PowerPlugs, a platform for individual apps and ...
July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...
July 15, 2024 — HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power of ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...
July 12, 2024 — Researchers have developed a groundbreaking method for analyzing heart MRI scans with the help of ...
July 11, 2024 — Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
July 11, 2024 — Heart Test Laboratories, Inc. an artificial intelligence (AI)-powered medical technology company focused ...
July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...
July 10, 2024 — Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal ...